CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,186,600
- in 2 filings
Net −$1,186,600. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-04-20 | GIVEN BRUCE D Chief Operating Officer | Sale | −5,300 | $40.00 | $212K | 858,993 |
| 2020-04-20 | GIVEN BRUCE D Chief Operating Officer | Sale | −3,454 | $40.00 | $138K | 855,539 |
| 2020-04-20 | GIVEN BRUCE D Chief Operating Officer | Sale | −3,805 | $40.00 | $152K | 851,734 |
| 2020-04-20 | GIVEN BRUCE D Chief Operating Officer | Option exercise · Stock Option (right to buy) | −3,800 | 346,200 | ||
| 2020-04-20 | GIVEN BRUCE D Chief Operating Officer | Option exercise · Stock Option (right to buy) | −3,700 | 342,500 | ||
| 2020-04-20 | GIVEN BRUCE D Chief Operating Officer | Option exercise · Stock Option (right to buy) | −3,456 | 339,044 | ||
| 2020-04-20 | GIVEN BRUCE D Chief Operating Officer | Option exercise · Stock Option (right to buy) | −5,300 | 333,744 | ||
| 2020-04-15 | De Backer Marianne Director | Purchase | +500 | $35.40 | $18K | 16,000 |
| 2020-04-14 | GIVEN DOUGLAS B Director | Sale | −25,000 | $36.89 | $922K | 155,925 |
| 2020-04-14 | GIVEN DOUGLAS B Director | Gift | −1,112 | 154,813 | ||
| 2020-03-16 | De Backer Marianne Director | Purchase | +500 | $23.94 | $12K | 15,500 |
| 2020-03-12 | De Backer Marianne Director | Purchase | +500 | $24.80 | $12K | 15,000 |
| 2020-03-11 | De Backer Marianne Director | Purchase | +500 | $28.60 | $14K | 14,500 |
| 2020-02-28 | De Backer Marianne Director | Purchase | +500 | $34.39 | $17K | 14,000 |
| 2020-02-27 | De Backer Marianne Director | Purchase | +500 | $35.07 | $18K | 13,500 |
| 2020-02-25 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise | +12,000 | $9.90 | $119K | 396,223 |
| 2020-02-25 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise | +2,000 | $5.19 | $10K | 398,223 |
| 2020-02-25 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise | +6,495 | $14.54 | $94K | 404,718 |
| 2020-02-25 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise | +12,116 | $7.75 | $94K | 416,834 |
| 2020-02-25 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise | +10,834 | $6.15 | $67K | 427,668 |
Page 25 of 38 · 752 trades